D.E. Shaw & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.42M | Buy |
|
|||||
|
2025
Q2 | $2.04M | Buy |
|
|||||
|
2025
Q1 | $1.25M | Sell |
|
|||||
|
2024
Q4 | $55.3M | Sell |
|
|||||
|
2024
Q3 | $65.9M | Sell |
|
|||||
|
2024
Q2 | $95.6M | Buy |
|
|||||
|
2024
Q1 | $27.1M | Buy |
|
|||||
|
2023
Q4 | $15.8M | Sell |
|
|||||
|
2023
Q3 | $61.6M | Buy |
|
|||||
|
2023
Q2 | $41.1M | Buy |
|
|||||
|
2023
Q1 | $12.5M | Sell |
|
|||||
|
2022
Q4 | $20.2M | Sell |
|
|||||
|
2022
Q3 | $31.8M | Buy |
|
|||||
|
2022
Q2 | $9.87M | Sell |
|
|||||
|
2022
Q1 | $34.1M | Buy |
|
|||||
|
2021
Q4 | $17.4M | Sell |
|
|||||
|
2021
Q3 | $26.3M | Buy |
|
|||||
|
2021
Q2 | $1.02M | Buy |
|
|||||
|
2021
Q1 | $863K | Sell |
|
|||||
|
2020
Q4 | $6.6M | Buy |
|
|||||
|
2020
Q3 | $2.81M | Buy |
|
|||||
|
2020
Q2 | $2.02M | Sell |
|
|||||
|
2020
Q1 | $3.7M | Buy |
|
|||||
|
2019
Q4 | $3.92M | Sell |
|
|||||
|
2019
Q3 | $17.1M | Sell |
|
|||||
|
2019
Q2 | $26.6M | Buy |
|
|||||
|
2019
Q1 | $3.22M | Sell |
|
|||||
|
2018
Q4 | $9.97M | Buy |
|
|||||
|
2018
Q3 | $8.16M | Buy |
|
|||||
|
2018
Q2 | $6.3M | Sell |
|
|||||
|
2018
Q1 | $21.6M | Sell |
|
|||||
|
2017
Q4 | $28M | Sell |
|
|||||
|
2017
Q3 | $26.5M | Buy |
|
|||||
|
2017
Q2 | $18.6M | Sell |
|
|||||
|
2017
Q1 | $49.2M | Sell |
|
|||||
|
2016
Q4 | $86.7M | Sell |
|
|||||
|
2016
Q3 | $220M | Buy |
|
|||||
|
2016
Q2 | $238M | Sell |
|
|||||
|
2016
Q1 | $310M | Buy |
|
|||||
|
2015
Q4 | $263M | Sell |
|
|||||
|
2015
Q3 | $250M | Buy |
|
|||||
|
2015
Q2 | $192M | Buy |
|
|||||
|
2015
Q1 | $107M | Buy |
|
|||||
|
2014
Q4 | $76.5M | Sell |
|
|||||
|
2014
Q3 | $159M | Buy |
|
|||||
|
2014
Q2 | $128M | Buy |
|
|||||
|
2014
Q1 | $84.6M | Buy |
|
|||||
|
2013
Q4 | $20.3M | Sell |
|
|||||
|
2013
Q3 | $59.6M | Buy |
|
|||||
|
2013
Q2 | $38.1M | Buy |
|